# The Role of Remazolam in Reducing the Incidence of Postoperative Delirium in Elderly Patients

> **NCT05466279** · NA · COMPLETED · sponsor: **Fang Jun** · enrollment: 131 (actual)

## Conditions studied

- Postoperative Delirium

## Interventions

- **DRUG:** remazolam
- **DRUG:** Propofol
- **DRUG:** Midazolam

## Key facts

- **NCT ID:** NCT05466279
- **Lead sponsor:** Fang Jun
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-07
- **Primary completion:** 2023-10-30
- **Final completion:** 2023-10-30
- **Target enrollment:** 131 (ACTUAL)
- **Last updated:** 2024-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05466279

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05466279, "The Role of Remazolam in Reducing the Incidence of Postoperative Delirium in Elderly Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05466279. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*